Wout A. P. Breeman

7.9k citations

84 papers · 6.2k indexed · 2 hit papers · h-index 40

Epidemiology top 0.5%
Oncology top 0.5%
Radiology, Nuclear Medicine and Imaging top 0.5%
Neurology top 0.2%
Endocrinology, Diabetes and Metabolism top 2%

Co-authors: Marion de Jong Eric P. Krenning Willem H. Bakker E. P. Krenning P.P.M. Kooij Dik J. Kwekkeboom Bert F. Bernard Roelf Valkema
Topics: Neuroendocrine Tumor Research Advances (62 papers)Radiopharmaceutical Chemistry and Applications (41 papers)Lung Cancer Research Studies (30 papers)
Cited by: Neurology Oncology Epidemiology
Journals: The Lancet Accounts of Chemical Research Annals of Surgery
Partner nations: Netherlands United States Switzerland

In The Last Decade

Wout A. P. Breeman

83 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1993 1.2k citations E. P. Krenning, Dik J. Kwekkeboom et al. European Journal of Nuclear Medicine and Molecular Imaging profile →
LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN

1989 481 citations E. P. Krenning, Wout A. P. Breeman et al. The Lancet profile →

Peers

Countries citing papers authored by Wout A. P. Breeman

Since Specialization

Citations

This map shows the geographic impact of Wout A. P. Breeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wout A. P. Breeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wout A. P. Breeman more than expected).

Fields of papers citing papers by Wout A. P. Breeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wout A. P. Breeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wout A. P. Breeman. The network helps show where Wout A. P. Breeman may publish in the future.

Co-authorship network of co-authors of Wout A. P. Breeman

This figure shows the co-authorship network connecting the top 25 collaborators of Wout A. P. Breeman. A scholar is included among the top collaborators of Wout A. P. Breeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wout A. P. Breeman. Wout A. P. Breeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In Vivo Enzyme Inhibition Improves the Targeting of [ ¹⁷⁷ Lu]DOTA-GRP(13–27) in GRPR-Positive Tumors in Mice 2014 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown),Marleen Melis,Erik de Blois,Wout A. P. Breeman,Eric P. Krenning,Θεοδοσία Μάινα,Berthold A. Nock,Marion de Jong	10
2	A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues 2010 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown),Cristina Müller,(unknown),(unknown),Wout A. P. Breeman,Erik de Blois,Chris H. Bangma,Eric P. Krenning,Wytske M. van Weerden,Marion de Jong	66
3	Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats 2008 ·Nuklearmedizin - NuclearMedicine ·Bert F. Bernard,Wout A. P. Breeman,Flavio Forrer,Erik de Blois,Jack Hoppin,Martin Gotthardt,Otto C. Boerman,E. P. Krenning,Marion de Jong,Edgar J. Rolleman	40
4	Radiolabelled Regulatory Peptides for Imaging and Therapy 2007 ·Anti-Cancer Agents in Medicinal Chemistry ·Marion de Jong,T.J. Visser,Erik de Blois,Wout A. P. Breeman,D. J. Kwekkeboom,E. P. Krenning	33
5	111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy 2005 ·European Journal of Nuclear Medicine and Molecular Imaging ·Astrid Capello,Eric P. Krenning,Bert F. Bernard,Jean–Claude Reubi,Wout A. P. Breeman,Marion de Jong	40
6	Low-Dose-Rate Irradiation by ¹³¹ I Versus High-Dose-Rate External-Beam Irradiation in the Rat Pancreatic Tumor Cell Line CA20948 2004 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown),Astrid Capello,Bert F. Bernard,(unknown),Mark Konijnenberg,Wout A. P. Breeman,Eric P. Krenning,Marion de Jong	12
7	Radiolabeled RGD-DTPA-Tyr ³ -Octreotate for Receptor-Targeted Radionuclide Therapy 2004 ·Cancer Biotherapy and Radiopharmaceuticals ·Bert F. Bernard,Astrid Capello,Martin van Hagen,Wout A. P. Breeman,Ananth Srinivasan,Michelle Schmidt,Jack L. Erion,Arthur van Gameren,Eric P. Krenning,Marion de Jong	29
8	Tyr ³ -Octreotide and Tyr ³ -Octreotate Radiolabeled with ¹⁷⁷ Lu or ⁹⁰ Y: Peptide Receptor Radionuclide Therapy Results In Vitro 2003 ·Cancer Biotherapy and Radiopharmaceuticals ·Astrid Capello,Eric P. Krenning,Wout A. P. Breeman,Bert F. Bernard,Mark Konijnenberg,Marion de Jong	23
9	Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience 2002 ·Seminars in Nuclear Medicine ·Roelf Valkema,Marion de Jong,Willem H. Bakker,Wout A. P. Breeman,P.P.M. Kooij,Pieternella J. Lugtenburg,Frank H. de Jong,(unknown),Boen L.R. Kam,Wouter W. de Herder,Mats Stridsberg,Jan Lindemans,Geert Ensing,Eric P. Krenning	328
10	Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings 2002 ·Seminars in Nuclear Medicine ·Marion de Jong,Roelf Valkema,François Jamar,Larry K. Kvols,Dik J. Kwekkeboom,Wout A. P. Breeman,Willem H. Bakker,(unknown),Stanislas Pauwels,Eric P. Krenning	260
11	Tumour uptake of the radiolabelled somatostatin analogue [DOTA 0 ,TYR 3 ]octreotide is dependent on the peptide amount 1999 ·European Journal of Nuclear Medicine and Molecular Imaging ·Marion de Jong,Wout A. P. Breeman,Bert F. Bernard,Arthur van Gameren,(unknown),Willem H. Bakker,Marcel E. van der Pluijm,Theo J. Visser,Helmut R. Mäcke,Eric P. Krenning	84
12	Pre-clinical evaluation of [111In-DTPA-Pro1, Tyr4]bombesin, a new radioligand for bombesin-receptor scintigraphy 1999 ·International Journal of Cancer ·Wout A. P. Breeman,Marion de Jong,Bert F. Bernard,Dik J. Kwekkeboom,Ananth Srinivasan,Marcel E. van der Pluijm,Leo J. Hofland,Theo J. Visser,Eric P. Krenning	69
13	Internalization of [DOTA°,¹²⁵I‐Tyr³]Octreotide by Somatostatin Receptor–Positive Cells In Vitro and In Vivo: Implications for Somatostatin Receptor–Targeted Radio‐guided Surgery 1999 ·PubMed ·(unknown),Wout A. P. Breeman,Eric P. Krenning,Marion de Jong,Marlijn Waaijers,Peter M. van Koetsveld,Helmut R. Mäcke,Steven W. J. Lamberts	42
14	99mTc-MIBI, 99mTc-Tetrofosmin and 99mTc-Q12 In Vitro and In Vivo 1998 ·Nuclear Medicine and Biology ·Bert F. Bernard,Eric P. Krenning,Wout A. P. Breeman,Geert Ensing,(unknown),Willem H. Bakker,Theo J. Visser,Marion de Jong	43
15	Iodine-131 labelled octreotide: not an option for somatostatin receptor therapy 1996 ·European Journal of Nuclear Medicine and Molecular Imaging ·Willem H. Bakker,Wout A. P. Breeman,Marcel E. van der Pluijm,Marion de Jong,Theo J. Visser,Eric P. Krenning	20
16	Somatostatin Receptor: Scintigraphy and Radionuclide Therapy 1996 ·Digestion ·E. P. Krenning,P.P.M. Kooij,Stanislas Pauwels,Wout A. P. Breeman,P.T.E. Postema,(unknown),Roelf Valkema,Dik J. Kwekkeboom	106
17	Evaluation in vitro and in rats of161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy 1995 ·European Journal of Nuclear Medicine and Molecular Imaging ·Marion de Jong,Wout A. P. Breeman,Bert F. Bernard,Edgar J. Rolleman,(unknown),Theo J. Visser,Buddy Setyono-Han,Willem H. Bakker,Marcel E. van der Pluijm,Eric P. Krenning	66
18	Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsbreakdown → 1993 ·European Journal of Nuclear Medicine and Molecular Imaging ·E. P. Krenning,Dik J. Kwekkeboom,Willem H. Bakker,Wout A. P. Breeman,P.P.M. Kooij,H.Y. Oei,M. van Hagen,P.T.E. Postema,Marion de Jong,Jean Claude Reubi,T. J. Visser,Ambroos E.M. Reijs,Leo J. Hofland,Jan W. Koper,S. W. J. Lamberts	1193
19	In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats 1991 ·Life Sciences ·Willem H. Bakker,E. P. Krenning,J.C. Reubi,Wout A. P. Breeman,Buddy Setyono-Han,Marion de Jong,P.P.M. Kooij,Christian Bruns,P. Martin van Hagen,Peter Marbach,T.J. Visser,Jeanetta du Plessis,S. W. J. Lamberts	141
20	LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATINbreakdown → 1989 ·The Lancet ·E. P. Krenning,Wout A. P. Breeman,P.P.M. Kooij,Laméris Js,(unknown),J. W. Koper,L Ausema,Jean Claude Reubi,S.W.J. Lamberts	481

About Wout A. P. Breeman

Wout A. P. Breeman is a scholar working on Radiology, Nuclear Medicine and Imaging, Neurology and Epidemiology, having authored 84 papers that have together received 6.2k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (62 papers), Radiopharmaceutical Chemistry and Applications (41 papers) and Lung Cancer Research Studies (30 papers). The work is most often cited by research in Neurology (2.3k citations), Oncology (3.3k citations) and Epidemiology (4.1k citations). Wout A. P. Breeman has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Marion de Jong, Eric P. Krenning, Willem H. Bakker, E. P. Krenning, P.P.M. Kooij, Dik J. Kwekkeboom, Bert F. Bernard, Roelf Valkema, Leo J. Hofland and Jean Claude Reubi. Their work appears in journals such as The Lancet, Accounts of Chemical Research and Annals of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact